IN a previous paper,1 the clinical features of fluid retention complicating the use of guanethidine were discussed. Of 134 patients treated continuously for over a year, 44 (32.8 per cent) were observed to retain fluid and yet, comparing these with the 90 who apparently avoided the complication, no significant differences could be found in respect to age, previous renal disease, change in the frequency of micturition, or abnormality of the electrocardiogram. Although women preponderated among those developing fluid retention and there was a significant proportion of patients who had previously experienced edema in the fluid-retaining group, neither of these factors could account completely for the incidence of fluid retention.
It seemed likely that either the distinguishing factor between the two groups had been overlooked or no such factor existed and retention of fluid was a potential hazard for all patients treated with guanethidine.
In order to test the hypothesis that fluid retention is a potential risk in all patients treated, 12 patients given guanethidine and three treated with reserpine were selected for study during the first 12 months of their hypotensive treatment.
Material
The subjects were selected from new patients attending the hypertension clinic of the Royal Infirmary, Sheffield. The criteria for inclusion were the absence of signs or symptoms of heart failure or overt renal disease and the presence of normal serum electrolytes and blood urea. Patients with associated diseases were also excluded, although two had sustained small cerebrovascular accidents previously. The ing clinical signs of fluid retention. The remaining five were lost from the study after 6 months for varying reasons; their results are not included in this report.
One of the three patients treated with reserpine became depressed and sustained a small cerebrovascular accident at 3 months. Another developed dependent edema at 3 months and was given a diuretic in addition to reserpine. His blood volume, creatinine clearance, and exchangeable sodium were measured again at 12 months.
The results are shown in tables 1 and 2 and those of one patient treated with guanethidine and one with reserpine (and later diuretics) Changes occurring in a patient receiving reserpine. Diuretics added at 3 months. It has been suggested that the fall in blood pressure with its consequences for the renal _14e \\ ME(ANB circulation is the cause of fluid retention pro- A similar change was seen in two patients receiving reserpine. It is suggested that the hemodynamic changes produced by hypotensive drugs are insufficient completely to explain the observations. A direct effect of guanethidine on sodium reabsorption in the kidney may also be involved.
from heart-failure during parturition. He began to make observations on the symptoms of heart disease. . . Too much significance was attached to the mere presence of a murmur, and many persons were condemned to a life of inactivity who nowadays would have no restrictions on their activities. Mackenzie began by giving special attention to the irregularities of the heart-beat during pregnancy. He took records or tracings of the pulse at the wrist by means of the ordinary Dudgeon's sphygmograph. Then he devised methods for recording the pulsation of the jugular vein in the neck. For the purpose of recording he borrowed the drum commonly used in the physiological laboratory, but, finding this rather clumsy, he invented the polygraph which made simultaneous ink records of the pulsation at the wrist, in the neck and at the apex-beat. Once 
